Chongqing Lummy Pharmaceutical (300006) — Long-term Investment Intensity
Chongqing Lummy Pharmaceutical (300006) has a Long-term Investment Intensity of 14.4% as of September 2019. Long-term investments of CN¥519.44 Million represent 14.4% of total assets of CN¥3.60 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Chongqing Lummy Pharmaceutical asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Chongqing Lummy Pharmaceutical Long-term Investment Intensity (2015–2018)
This chart shows how Chongqing Lummy Pharmaceutical's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 14.4%, reflecting long-term investments of CN¥519.44 Million against total assets of CN¥3.60 Billion CNY. For the complete balance sheet picture, see Chongqing Lummy Pharmaceutical balance sheet assets.
Annual Long-term Investment Intensity for Chongqing Lummy Pharmaceutical (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Chongqing Lummy Pharmaceutical from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Chongqing Lummy Pharmaceutical (300006) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 16.0% | CN¥502.58 Million | CN¥3.14 Billion | ▲ +4.7 pp |
| 2017 | 11.3% | CN¥309.38 Million | CN¥2.74 Billion | ▲ +6.5 pp |
| 2016 | 4.8% | CN¥118.99 Million | CN¥2.48 Billion | ▲ +2.9 pp |
| 2015 | 1.9% | CN¥58.60 Million | CN¥3.10 Billion | — |